TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.
Clinical trial NCT00744809 · COMPLETED
Trial details
- NCT number
- NCT00744809
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.